Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-03-14$5.60/sh−2,266$12,683→ 41,566 total
Footnotes (1)
- [F1]These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.